Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Carr

Showing results (91-100 of 94) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 94 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 27, 2006
A phase I study assessing the safety and pharmacokinetics of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 with gemcitabine and cisplatin in patients with solid tumorsJ A Gietema, R Hoekstra, F Y F L de Vos, et al.
The British Journal of Surgery|September 3, 2021
Prognosis after neoadjuvant chemoradiation or chemotherapy for locally advanced gastro-oesophageal junctional adenocarcinomaE L Vos, R A Carr, M Hsu, et al.
Journal of Medicinal Chemistry|October 6, 2000
Synthesis and SAR of new 5-phenyl-3-ureido-1,5-benzodiazepines as cholecystokinin-B receptor antagonistsA Ursini, A M Capelli, R A Carr, et al.
Journal of Medicinal Chemistry|January 19, 1996
Discovery of 1,5-benzodiazepines with peripheral cholecystokinin (CCK-A) receptor agonist activity. 1. Optimization of the agonist "trigger"C J Aquino, D R Armour, J M Berman, et al.
Pageof 10

Showing results (91-100 of 94) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 94 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 27, 2006
A phase I study assessing the safety and pharmacokinetics of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 with gemcitabine and cisplatin in patients with solid tumorsJ A Gietema, R Hoekstra, F Y F L de Vos, et al.
The British Journal of Surgery|September 3, 2021
Prognosis after neoadjuvant chemoradiation or chemotherapy for locally advanced gastro-oesophageal junctional adenocarcinomaE L Vos, R A Carr, M Hsu, et al.
Journal of Medicinal Chemistry|October 6, 2000
Synthesis and SAR of new 5-phenyl-3-ureido-1,5-benzodiazepines as cholecystokinin-B receptor antagonistsA Ursini, A M Capelli, R A Carr, et al.
Journal of Medicinal Chemistry|January 19, 1996
Discovery of 1,5-benzodiazepines with peripheral cholecystokinin (CCK-A) receptor agonist activity. 1. Optimization of the agonist "trigger"C J Aquino, D R Armour, J M Berman, et al.
Pageof 10